These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 10757257)

  • 1. Selective serotonin reuptake inhibitors in post-traumatic stress disorder.
    Hidalgo RB; Davidson JR
    J Psychopharmacol; 2000 Mar; 14(1):70-6. PubMed ID: 10757257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment-resistant anxiety disorders: A literature review of drug therapy strategies].
    Ammar G; Naja WJ; Pelissolo A
    Encephale; 2015 Jun; 41(3):260-5. PubMed ID: 25439852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
    Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations.
    Asnis GM; Kohn SR; Henderson M; Brown NL
    Drugs; 2004; 64(4):383-404. PubMed ID: 14969574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders.
    Figgitt DP; McClellan KJ
    Drugs; 2000 Oct; 60(4):925-54. PubMed ID: 11085201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased suicidal ideation in depressed patients with or without comorbid posttraumatic stress disorder treated with selective serotonin reuptake inhibitors: an open study.
    Sher L; Stanley BH; Posner K; Arendt M; Grunebaum MF; Neria Y; Mann JJ; Oquendo MA
    Psychiatry Res; 2012 Apr; 196(2-3):261-6. PubMed ID: 22397913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triiodothyronine augmentation of selective serotonin reuptake inhibitors in posttraumatic stress disorder.
    Agid O; Shalev AY; Lerer B
    J Clin Psychiatry; 2001 Mar; 62(3):169-73. PubMed ID: 11305702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors.
    Zohar J; Westenberg HG
    Acta Psychiatr Scand Suppl; 2000; 403():39-49. PubMed ID: 11019934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Where are we going with SSRIs?
    Isaac M
    Eur Neuropsychopharmacol; 1999 Jul; 9 Suppl 3():S101-6. PubMed ID: 10523065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of traumatized refugees with sertraline versus venlafaxine in combination with psychotherapy - study protocol for a randomized clinical trial.
    Sonne C; Carlsson J; Elklit A; Mortensen EL; Ekstrøm M
    Trials; 2013 May; 14():137. PubMed ID: 23663588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of pharmacotherapy for PTSD: an effect size analysis of controlled studies.
    Penava SJ; Otto MW; Pollack MH; Rosenbaum JF
    Depress Anxiety; 1996-1997; 4(5):240-2. PubMed ID: 9167791
    [No Abstract]   [Full Text] [Related]  

  • 12. The impact of trauma and post-traumatic stress disorder on the treatment response of patients with obsessive-compulsive disorder.
    Shavitt RG; Valério C; Fossaluza V; da Silva EM; Cordeiro Q; Diniz JB; Belotto-Silva C; Cordioli AV; Mari J; Miguel EC
    Eur Arch Psychiatry Clin Neurosci; 2010 Mar; 260(2):91-9. PubMed ID: 20077119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WCA Recommendations for the long-term treatment of posttraumatic stress disorder.
    Stein DJ; Bandelow B; Hollander E; Nutt DJ; Okasha A; Pollack MH; Swinson RP; Zohar J;
    CNS Spectr; 2003 Aug; 8(8 Suppl 1):31-9. PubMed ID: 14767396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spotlight on paroxetine in psychiatric disorders in adults.
    Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
    CNS Drugs; 2002; 16(6):425-34. PubMed ID: 12027788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open-label trial of escitalopram in the treatment of posttraumatic stress disorder.
    Robert S; Hamner MB; Ulmer HG; Lorberbaum JP; Durkalski VL
    J Clin Psychiatry; 2006 Oct; 67(10):1522-6. PubMed ID: 17107242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Selective Serotonin Reuptake Inhibitors on Healthcare Utilization in Patients with Post-Traumatic Stress Disorder and Alcohol Use Disorder.
    Naglich AC; Bozeman S; Brown ES; Adinoff B
    Alcohol Alcohol; 2019 Jul; 54(4):428-434. PubMed ID: 31185085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does comorbid anxiety or depression affect clinical outcomes in patients with post-traumatic stress disorder and alcohol use disorders?
    Labbate LA; Sonne SC; Randal CL; Anton RF; Brady KT
    Compr Psychiatry; 2004; 45(4):304-10. PubMed ID: 15224273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopharmacological treatment for military posttraumatic stress disorder: an integrative review.
    Tawa J; Murphy S
    J Am Assoc Nurse Pract; 2013 Aug; 25(8):419-423. PubMed ID: 24170638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of neurosteroid biosynthesis as a pharmacological strategy to improve behavioural deficits in a putative mouse model of post-traumatic stress disorder.
    Pinna G; Rasmusson AM
    J Neuroendocrinol; 2012 Jan; 24(1):102-16. PubMed ID: 21981145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiepileptic drugs for the treatment of post-traumatic stress disorder.
    Berlin HA
    Curr Psychiatry Rep; 2007 Aug; 9(4):291-300. PubMed ID: 17880860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.